Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 3, Issue 3-4
October 2014
Issue Cover
All Issues
ISSN 2235-1795
EISSN 1664-5553
In this Issue

Liver Cancer 2014, Vol. 3, No. 3-4

 

The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014), A Bridge to a Consensus on HCC Management, Taipei, Taiwan, July 11-13, 2014: Abstracts
Subject Area: Gastroenterology , Oncology
Liver Cancer (2014) 3 (3-4): 285–397. https://doi.org/10.1159/000343874
View articletitled, The 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014), A Bridge to a Consensus on HCC Management, Taipei, Taiwan, July 11-13, 2014: Abstracts
Open the PDF for in another window

Editorial

Biomarkers and Personalized Sorafenib Therapy
Subject Area: Gastroenterology , Oncology
Liver Cancer (2014) 3 (3-4): 399–404. https://doi.org/10.1159/000343870
View articletitled, Biomarkers and Personalized Sorafenib Therapy
Open the PDF for in another window

Review

Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
Subject Area: Gastroenterology , Oncology
Chihwan Choi; Gi Hong Choi; Tae Hyun Kim; Masatoshi Tanaka; Mao-Bin Meng; Jinsil Seong
Liver Cancer (2014) 3 (3-4): 405–416. https://doi.org/10.1159/000343861
View articletitled, Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
Open the PDF for in another window
Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications
Subject Area: Gastroenterology , Oncology
Naoshi Nishida; Masatoshi Kudo
Liver Cancer (2014) 3 (3-4): 417–427. https://doi.org/10.1159/000343860
View articletitled, Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications
Open the PDF for in another window
Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law
Subject Area: Gastroenterology , Oncology
Gerond Lake-Bakaar; Muneeb Ahmed; Amy Evenson; Alan Bonder; Salomao Faintuch; Vinay Sundaram
Liver Cancer (2014) 3 (3-4): 428–438. https://doi.org/10.1159/000343871
View articletitled, Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law
Open the PDF for in another window
Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
Subject Area: Gastroenterology , Oncology
Jean-Luc Raoul; Joong-Won Park; Yoon-Koo Kang; Richard S Finn; Jun Suk Kim; Winnie Yeo; Blasé N Polite; Yee Chao; Ian Walters; Christine Baudelet; Riccardo Lencioni
Liver Cancer (2014) 3 (3-4): 439–450. https://doi.org/10.1159/000343872
View articletitled, Using Modified RECIST and Alpha-Fetoprotein Levels to Assess Treatment Benefit in Hepatocellular Carcinoma
Open the PDF for in another window
Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma
Subject Area: Gastroenterology , Oncology
Kathryn Effendi; Ken Yamazaki; Mariko Fukuma; Michiie Sakamoto
Liver Cancer (2014) 3 (3-4): 451–457. https://doi.org/10.1159/000343873
View articletitled, Overexpression of Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5 (LGR5) Represents a Typical Wnt/β-Catenin Pathway-Activated Hepatocellular Carcinoma
Open the PDF for in another window
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
Subject Area: Gastroenterology , Oncology
Masatoshi Kudo; Osamu Matsui; Namiki Izumi; Hiroko Iijima; Masumi Kadoya; Yasuharu Imai; Takuji Okusaka; Shiro Miyayama; Kaoru Tsuchiya; Kazuomi Ueshima; Atsushi Hiraoka; Masafumi Ikeda; Sadahisa Ogasawara; Tatsuya Yamashita; Tetsuya Minami; Koichiro Yamakado; on behalf of the Liver Cancer Study Group of Japan
Liver Cancer (2014) 3 (3-4): 458–468. https://doi.org/10.1159/000343875
View articletitled, JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan
Open the PDF for in another window
Treatment duration of adjuvant immune checkpoint inhibitors in hepatocellular carcinoma patients at high risk of recurrence after resection: A prospective, multicentric cohort study
Immunometabolic Targets in CD8+ T Cells within the Tumor Microenvironment of Hepatocellular Carcinoma
Acknowledgement to Reviewers
First-Line Lenvatinib Plus Pembrolizumab for Hepatocellular Carcinoma: Post Hoc Analysis of Japanese Patients From the Phase 3 LEAP-002 Trial
  • Online ISSN 1664-5553
  • Print ISSN 2235-1795
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal